Cart
sales@molnova.com
WEB-1868
CAS No. 96449-69-3
WEB-1868( WEB 1868 | WEB1868 )
Catalog No. M27215 CAS No. 96449-69-3
WEB-1868 is an agent of biochemical.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 51 | In Stock |
|
| 50MG | 75 | In Stock |
|
| 100MG | 112 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 276 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWEB-1868
-
NoteResearch use only, not for human use.
-
Brief DescriptionWEB-1868 is an agent of biochemical.
-
DescriptionWEB-1868 is an agent of biochemical.
-
In Vitro——
-
In Vivo——
-
SynonymsWEB 1868 | WEB1868
-
PathwayOthers
-
TargetOther Targets
-
RecptorM1 muscarininc
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number96449-69-3
-
Formula Weight205.257
-
Molecular FormulaC12H15NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOCC1CN(Cc2ccccc2)C(=O)C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sheffler DJ, et al. A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning. Mol Pharmacol. 2009 Aug;76(2):356-68.
molnova catalog
related products
-
Elamipretide TFA
Elamipretide TFA is a cardiolipin peroxidase inhibitor and mitochondria-targeting peptide.
-
FK962
FK962 is an somatostatin release enhancer exerts cognitive-enhancing actions.
-
DCZ0415
DCZ0415 induces antimyeloma activity in vitro, in vivo and in primary cells of drug-resistant myeloma patients. DCZ0415 is a potent TRIP13 inhibitor that can impair the repair of non-homologous end junctions and inhibit NF-κB activity.DCZ0415 (10, 20 μM; 72 hours) showed a marked reduction in colony formation, indicating that it inhibited cell proliferation.
